
Dabmit 150mg Tablet
Marketer
Mits Healthcare Pvt Ltd
Salt Composition
Dabigatran Etexilate (150mg)
Overview Dabmit 150mg Tablet
CardioGuard 150mg tablets function as an anticoagulant, preventing and treating blood clots. This medication diminishes the risk of stroke and heart attack by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for individuals with atrial fibrillation to prevent clotting, CardioGuard 150mg is also used post-knee or hip replacement surgery to mitigate clot risk. Administer with or without food, maintaining consistent daily timing. Long-term, even lifelong, use may be necessary; discontinue or alter dosage only under physician supervision, as abrupt cessation significantly increases stroke, heart attack, and thrombosis risk. Lifestyle modifications, including diet, exercise, smoking cessation, and weight management (if needed), further reduce clotting risk. Common side effects include gastrointestinal discomfort and increased bleeding susceptibility (e.g., nosebleeds, bruising). Report any adverse effects immediately. Other potential side effects encompass headaches, seizures, allergic responses, visual disturbances, and fatigue. Contraindicated in patients with severe hepatic or renal impairment, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't required.
Uses of Dabmit 150mg Tablet
Managing and averting blood clot formation
Major Benefits of Dabmit 150mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dabmit 150mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Dabmit 150mg Tablet:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabmit 150mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dabmit 150mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Dabmit 150mg Tablet works:
Xylothrom 150mg tablets represent a new class of oral anticoagulants, effectively inhibiting blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while taking Dabmit 150mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dabmit 150mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Dabmit 150mg tablets while breastfeeding is likely inadvisable. Scant available human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dabmit 150mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Dabmit 150mg tablets, as dose modification may be necessary. Physician consultation is advised. Dabmit 150mg tablets are contraindicated in patients with severe renal disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Dabmit 150mg tablets. Dosage modification of Dabmit 150mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Dabmit 150mg Tablet :
Should you forget a Dabmit 150mg Tablet dose, ingest it immediately upon remembrance that same day. However, omit the missed dose if it's impossible to administer it at least six hours prior to your next planned dose. Never compensate for a missed dose by doubling the next one.
Facts to Know About Dabmit 150mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | HEART |
| Actions | Oral direct thrombin inhibitor |
